Tuberculosis is still the deadliest infectious disease in the world, driven by Mycobacterium tuberculosis and its complex cell envelope. Phosphatidyl-myo-inositol mannosides—the most abundant glycolipids in that envelope—act as structural scaffolds and help shape how the bacterium interacts with its host. A 2025 Nature Communications study reported the first high-resolution cryo-EM structures of the mannosyltransferase PimE, shedding light on the molecular details of a key step in PIM glycolipid biosynthesis. Here we look at how PimE recognizes its substrates and carries out glycosyl transfer, what these findings mean for anti-tuberculosis drug targeting, and what technical capabilities are needed to support this kind of research.
PIMs represent the most abundant class of glycolipids in the mycobacterial cell envelope. PimE occupies a central position in this pathway, catalyzing the transfer of the fifth mannose residue from a lipid-linked donor to a tetramannoside acceptor. This step directly determines whether higher mannosylated PIMs can be generated, influencing envelope integrity, antibiotic permeability, and host-pathogen interactions.
Fig. 1. PIM biosynthesis pathway and PimE structural architecture.1,4
The biosynthesis of PIMs begins on the cytoplasmic side, where PimA and PimB sequentially transfer mannose residues from GDP-mannose to phosphatidylinositol, generating PIM1 and PIM2. This is followed by acylation catalyzed by PatA, producing Ac1PIM2. These intermediates are then translocated across the membrane, where PimC, PimD, and PimE catalyze further mannose additions.
Each enzymatic step contributes to the structural diversity and functional properties of glycolipids. The precise coordination between glycosylation and lipid modification ultimately determines the composition and biological role of PIMs within the mycobacterial cell envelope.
Genetic studies first highlighted the importance of PimE. Knockout of the pimE gene leads to a dramatic accumulation of Ac1PIM4, while downstream products Ac1PIM5 and Ac1PIM6 are nearly absent. This shift in glycolipid composition triggers profound physiological consequences:
These phenotypic changes establish PimE as a regulatory bottleneck in glycolipid biosynthesis rather than a simple catalytic enzyme.
Despite its functional importance, PimE's catalytic mechanism remained speculative. The only clue came from sequence alignment identifying D58 as critical. However, how substrates bind and how the catalytic reaction proceeds lacked direct structural evidence, as PimE is a 46 kDa membrane protein challenging for traditional structure determination methods.
Recent advances in cryo-electron microscopy have transformed the study of membrane proteins. In this work, researchers combined single-particle cryo-EM with nanodisc reconstitution and antibody fragment stabilization to resolve PimE structures in both apo and substrate-bound states at resolutions of 3.0 Å and 3.5 Å, respectively.
This represents the first atomic-level visualization of a mannosyltransferase involved in PIM glycolipid biosynthesis and provides a structural framework for understanding substrate recognition within the GT-C superfamily.
PimE consists of 12 transmembrane helices forming an elongated, cashew-shaped cavity that runs nearly parallel to the membrane plane. This unique architecture allows the enzyme to simultaneously accommodate two chemically distinct substrates.
One end of the cavity is hydrophobic and interacts with the polyprenyl tail of the donor substrate PPM. The opposite end is more hydrophilic, enabling binding of the glycan headgroup of Ac1PIM4. This spatial separation ensures precise positioning of both substrates within a confined membrane environment.
Fig. 2. The putative substrate-binding cavity of PimE.2,4
The substrate-bound structure reveals that residue D58 is positioned at the tip of the JM1 helix, forming a hydrogen bond with the C2 hydroxyl group of the fifth mannose. This positioning is consistent with catalytic aspartates observed in other GT-C enzymes.
Surrounding D58 is a coordinated network of residues:
Biochemical assays further demonstrate that PimE activity is unaffected by metal chelators or magnesium ions, confirming that it operates through a metal-independent catalytic mechanism.
Comparison of apo and product-bound structures shows substrate binding triggers ordered transition of multiple loops. The IL7 loop connecting JM3 and JM4 folds into an arch-like channel in the product-bound state, through which donor PPM enters the active site with its polyprenyl tail extending along transmembrane helix 6.
Fig. 3. Cryo-EM structure of product-bound PimE and active site details.3,4
Structural elucidation requires validation through functional experiments. This study constructed a multi-tiered validation chain from in vitro enzyme assays to in vivo glycolipid profiling.
Wild-type and mutant PimE were expressed in E. coli, and membrane fractions were incubated with Ac1PIM4 and radiolabeled PPM. D58A and D58N completely abolished activity, confirming D58 as the catalytic base. K195A and W319A also resulted in complete loss, while H321A and H322A showed reduced but detectable activity.
Mutant PimE variants were complemented into M. smegmatis ΔpimE strains. D58A and Y62A complemented strains showed Ac1PIM4 accumulation with no Ac1PIM6 production, identical to ΔpimE. H321A and H322A complemented strains retained partial function with detectable Ac1PIM6, demonstrating the quantitative relationship between PimE activity and the glycolipid metabolic network.
MD simulations revealed loop region fluctuations were significantly reduced in the presence of ligands, consistent with structural observations. Analysis of pKa changes for D58 and K195 suggested dynamic protonation state transitions during the catalytic cycle, providing insights into metal-independent catalysis.
Integrating structural, computational, and functional data, this study proposes a comprehensive model for PimE-catalyzed glycosyl transfer.
PPM enters through the arch formed by IL7, with its polyprenyl tail extending along transmembrane helices 6 and 9. Ac1PIM4 enters from the opposite end, with its sugar head positioned near D58 and acyl chains extending toward helix 3. Both pathways converge at the active center.
A four-step model describes the catalytic cycle:
PimE achieves metal-independent catalysis through precise substrate positioning via spatial constraints and hydrogen bonds, phosphate stabilization by K195 and H322 electrostatic interactions, and D58 activation stabilized by Y62.
Each step in glycolipid biosynthesis research relies on specific technical capabilities that represent practical bottlenecks for many laboratories.
High-purity Ac1PIM4 and PPM were essential for structure determination. Ac1PIM4 required extraction from M. smegmatis ΔpimE membranes; PPM required heterologous expression and enzymatic synthesis. This approach faces challenges: lengthy extraction procedures, batch-to-batch variability, and inability to generate structural analogs for SAR studies.
As a 46 kDa membrane protein, PimE required nanodisc reconstitution and antibody fragment screening for cryo-EM. Successful implementation depends on efficient membrane protein expression, nanodisc self-assembly optimization, and antibody screening, placing high demands on laboratory expertise.
Complex glycolipids require rigorous characterization beyond conventional TLC and UV. High-field NMR and high-resolution MS are essential for confirming glycosidic linkages, lipid backbone configurations, and acyl substitution patterns, representing a hidden bottleneck for laboratories without dedicated platforms.
BOC Sciences has established a service system covering custom glycolipid synthesis and high-precision structural characterization to help researchers bypass substrate acquisition and sample validation barriers.
Our glycolipid synthesis platform enables production of structurally complex glycolipids including PIMs, gangliosides, glycosphingolipids, and phosphoglycolipids. Capabilities include:
Our structural characterization platform provides comprehensive validation:
BOC Sciences provides reliable support for glycolipid biosynthesis research, from custom synthesis of complex glycolipids to high-precision structural characterization. Our team ensures each sample meets strict quality standards, enabling researchers to focus on mechanistic studies without technical barriers.
Contact our experts today to discuss your glycolipid synthesis and analysis needs and get tailored solutions for your research projects.
References
